The Medicine Forum
Volume 14

Article 4

2013

Cerebrovascular Accident Caused by Embolic
Atrial Myxoma
Eugene Han, MD
Thomas Jefferson University Hospitals, Eugene.Han@jefferson.edu

Andrew Garrett, MD
Thomas Jefferson University Hospitals, Andrew.Garrett@jefferson.edu

Follow this and additional works at: https://jdc.jefferson.edu/tmf
Part of the Medicine and Health Sciences Commons

Let us know how access to this document benefits you
Recommended Citation
Han, MD, Eugene and Garrett, MD, Andrew (2013) "Cerebrovascular Accident Caused by Embolic Atrial Myxoma," The Medicine
Forum: Vol. 14 , Article 4.
DOI: https://doi.org/10.29046/TMF.014.1.005
Available at: https://jdc.jefferson.edu/tmf/vol14/iss1/4

This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
The Medicine Forum by an authorized administrator of the Jefferson Digital Commons. For more information, please contact:
JeffersonDigitalCommons@jefferson.edu.

Han, MD and Garrett, MD: Cerebrovascular Accident Caused by Embolic Atrial Myxoma

Cerebrovascular Accident Caused by Embolic Atrial
Myxoma
Eugene Han, MD, Andrew Garrett, MD

Background
Atrial myxomas, the most common type of cardiac tumors, can
cause life-threatening complications. As most cardiac myxomas
are surgically curable, early diagnosis is crucial. Cardiac tumors
can present with cardiac and embolic manifestations, and should
be considered in the differential diagnosis of patients presenting
with such symptoms. In this case report, we describe a young,
healthy patient who presented with stroke symptoms secondary
to embolic atrial myxoma.

Case Presentation
A 45-year-old male with no past medical history presented with
an acute onset of dysarthria, described as garbled speech. He also
experienced weakness and heaviness of his right hand, which
impaired his ability to brush his teeth and write. He denied
left-handed or lower extremity weakness, head trauma, facial
droop, dysphagia, migraines, diplopia/visual changes, confusion,
or memory loss. He denied tobacco, alcohol, or drug use. Review
of systems was otherwise negative, although the patient reported
that whenever he participated in strenuous physical activity over
the past few years, he would become nauseated.

thorax revealed a hypoattenuating 3.7 x 2.4 cm lesion in the left
atrium. Transesophageal echocardiogram (TEE) confirmed a
large (5 x 3.2 cm), irregular, gelatinous mass, with frond-like,
mobile edges attached to the fossa ovalis, and broad 1 cm stalk.
This mass prolapsed into the mitral valve orifice during diastole,
likely representing a left atrial myxoma.

Treatment
Four days after presentation to TJUH, the patient underwent
robotic-assisted excision of the myxoma. There were no intraoperative complications, and post-procedure TEE revealed resolution
of the left atrial myxoma without mitral valvular insufficiency.
The patient required pressors and inotropic support for 2 days
post-operatively for persistent hypotension. He was discharged
home in stable condition on post-operative day #3.

Investigations
The patient initially presented to an outside hospital after his
symptoms persisted for over 24 hours. Computed tomography
(CT) of the head was negative for intracranial bleed and he
was discharged. While his dysarthria improved, he continued
to have weakness and went to another hospital for evaluation.
Brain magnetic resonance imaging (MRI) at the second hospital
showed two acute left basal ganglia infarcts. As part of the
stroke workup, he had an echocardiogram, which revealed a 5
cm left atrial myxoma. He was transferred to Thomas Jefferson
University Hospital (TJUH) for further management.
On presentation to the TJUH Cardiac Critical Care Unit (CCU),
the patient’s vital signs were as follows: temperature 98.2°F, blood
pressure 142/80 mm Hg, pulse 100 beats per minute, respiratory
rate 19 breaths per minute. Cardiac examination was notable for
a soft diastolic rumble heard best in the left upper parasternal
area. Neurological examination revealed minor dysarthria. The
remainder of the physical examination was normal. Complete
blood count and basic metabolic panel were within normal
limits, and electrocardiogram showed sinus rhythm. C-reactive
protein (CRP) was elevated to 7.9 mg/dL. Chest radiograph was
unremarkable. CT head showed left basal ganglia and corona
radiata hypodensities consistent with recent infarction. CT
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Figure 1. Three-chamber parasternal long axis view on echocardiogram with arrow indicating left atrial myxoma

Discussion
Myxomas, the most common type of benign primary cardiac
tumor, account for approximately one-third of benign tumors
of the heart.1-3 They occur across all age groups, more commonly
in women and during the third through sixth decades.1,4-7 90%
of cases are sporadic, while the remainder are transmitted in an
autosomal dominant fashion. This inheritance typically occurs
as part of the Carney syndrome complex that includes myxomas,
lentigines/pigmented nevi, and endocrine overactivity. 1,8-12
The NAME (nevi, atrial myxoma, myxoid neurofibroma,
and ephelides) and LAMB (lentigines, atrial myxoma, and
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blue nevi) syndromes likely represent subsets of the Carney
complex.1,13 While the genetic origin of the Carney complex is
unclear, patients frequently have inactivating mutations of the
PRKAR1A tumor-suppressor gene.1,13

istics of myxomas.1,2 In the past, cardiac catheterization and
angiography were routinely performed prior to excision; their
role has diminished in favor of noninvasive imaging due to the
additional risk of tumor embolization during catheterization.1,32

Most myxomas arise in the left atrium from the interatrial
septum near the fossa ovalis.4,14 They are gelatinous structures
comprised of myxoma cells in a glycosaminoglycan-rich
stroma, often pedunculated on a fibrovascular stalk.1,14,15 They
arise from multipotent mesenchymal cells that persist from
embryonic cardiac septation and have been found to produce
vascular endothelial growth factor (VEGF), which is implicated
in the early stages of tumor growth.13-16

Definitive treatment for a myxoma is surgical excision; medical
therapy is only indicated for management of concomitant CHF
and/or arrhythmias.1,33,34 Septal defects and/or valvular damage
that occur during surgery may require repair.33,34 A potential
complication of excision is fragmentation and embolization of
part of the tumor.33,34 While thrombolytic therapy is reasonable
for stroke secondary to blood clot emboli from cardiac myxomas,
it has little effect on emboli composed of actual tumor.35 Overall
post-surgical prognosis is excellent, with a 3% rate of operative
mortality.1,19,33,34 Recurrence is rare in sporadic cases (1-2%) and
usually due to inadequate resection; familial myxomas recur in
12-22% of cases and are likely due to multifocal lesions.1,2,19,27
Follow-up includes routine semi-annual echocardiography.
Screening of first-degree relatives is appropriate due to the
possibility of familial inheritance.1

Depending on location, myxomas can cause the signs and
symptoms of corresponding valvular disease; atrial myxomas
can mimic atrioventricular (AV) valve stenosis due to valve
obstruction, while ventricular myxomas can cause outflow
obstruction similar to subaortic or subpulmonic stenosis. 1,3
Diastolic murmurs result from obstruction of the filling
ventricle, while systolic murmurs arise when valve closure or
outflow is interrupted. 3 The characteristic “diastolic tumor
plop,” a low-pitched sound during early to mid-diastole, is
thought to represent the physical impact of the tumor hitting
the AV valve or ventricular wall.1 Repetitive trauma to the valve
may also cause damage and regurgitation due to a “wrecking
ball” phenomenon.17 Congestive heart failure (CHF) may result
from obstruction of cardiac flow and/or impaired contractility
from direct invasion of the myocardium (myocardial damage
may also cause arrhythmias, heart block, pericardial effusion
or tamponade). 2,18,19 Symptoms may provide a clue to the
tumor’s location: left-sided tumors may present with dyspnea
on exertion, orthopnea or flash pulmonary edema; right-sided
tumors may present with syncope, sudden death or right
heart failure. 2, 18-21 Of note, these symptoms can be sudden
and/or positional due to the effect of gravity on the tumor’s
position.1,2,18,19 Fragments of myxomas may embolize and cause
signs of peripheral or pulmonary emboli, as well as fever, weight
loss, malaise, arthralgias, rash, digital clubbing, and Raynaud’s
phenomenon.1,2,22-28 Laboratory abnormalities associated with
myxomas include anemia, leukocytosis, thrombocytopenia/
cytosis, elevated erythrocyte sedimentation rate (ESR) and
CRP.1,2,22 Rarely, myxomas may become infected; the incidence
of cerebral and systemic emboli from infected myxomas is
greater than that from non-infected myxomas.29 Management of
these patients is often complicated by bacteremia, septic shock,
disseminated intravascular coagulation (DIC), multi-organ
failure, and cerebral infarction.30
Echocardiography is useful in diagnosing myxomas; tumor size,
shape, and attachment can be assessed, all of which assist in
surgical planning for excision.1,3,18,31 TEE offers superior imaging
compared to transthoracic echocardiography (TTE) owing to
the proximity of the esophagus to the heart and use of high
frequency transducers.31 Cardiac CT and MRI offer noninvasive
imaging options that can also help evaluate the character-
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Key Points
Although an uncommon cause of stroke, cardiac myxoma should
be considered in the differential diagnosis. Definitive treatment
is surgical resection, which offers excellent cure rates with rare
recurrence and low mortality. Medical management is supportive.
Once a cardiac myxoma has been identified, arrangements for
surgical resection should be made immediately.
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